# Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers

> **NCT05532293** · PHASE1 · COMPLETED · sponsor: **Godavari Biorefineries Limited** · enrollment: 64 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** MSP008-22
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05532293
- **Lead sponsor:** Godavari Biorefineries Limited
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-02
- **Primary completion:** 2025-11-10
- **Final completion:** 2025-11-10
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05532293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05532293, "Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05532293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*